𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer

✍ Scribed by C. Vanhaelen; M. Bertrand; R. De Jager; Y. Kenis


Book ID
113146266
Publisher
Elsevier Science
Year
1979
Weight
275 KB
Volume
15
Category
Article
ISSN
0014-2964

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Chemotherapy for head and neck cancer. C
✍ Stephen D. Williams; Enrique Velez-Garcia; Issac Essessee; Gary Ratkin; Robert B πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 575 KB

One hundred ninety-one patients with recurrent or metastatic squamous cell carcinoma of head and neck origin were allocated at random to chemotherapy with conventional-dose weekly intravenous methotrexate or the combination of cisplatin, vinblastine, and bleomycin. Methotrexate induced responses in

Radiochemotherapy with Vinblastine, Meth
✍ PrimoΕΎ Strojan; Erika Ε oba; Marjan Budihna; Marija Auersperg πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

Objective: To explore whether the combined radiochemotherapy with Vinblastine, Methotrexate, and Bleomycin could be an effective alternative treatment to surgery in verrucous carcinoma (VC) of the head and neck. Methods: Combined radiochemotherapy was used in 12 patients with previously untreated VC

Chemotherapy of head and neck cancer: Co
✍ Wittes, Robert E. ;Spiro, Ronald H. ;Shah, Jatin ;Gerold, Frank P. ;Koven, Berna πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 470 KB πŸ‘ 1 views

## Abstract A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50

A randomized prospective comparison of m
✍ Steven E. Vogl; David A. Schoenfeld; Barry H. Kaplan; Harvey J. Lerner; Paul F. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 1020 KB

Combination chemotherapy with methotrexate, bleomycin, and cis-diamminedichloroplatinum (11) was compared to weekly therapy with methotrexate alone in a randomized prospective trial in 163 patients with recurrent or metastatic squamous cancer of the mucous membranes of the head and neck. The combina